These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7022832)

  • 1. Lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity in patients with aplastic anemia: distinguishing transfusion-induced sensitization from possible immune-mediated aplastic anemia.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1981 Mar; 13(1 Pt 1):245-7. PubMed ID: 7022832
    [No Abstract]   [Full Text] [Related]  

  • 2. Difficulties in predicting bone-marrow graft rejection in patients with aplastic anemia.
    Elfenbein GJ; Anderson PN; Klein DL; Schacter BZ; Santos GW
    Transplant Proc; 1978 Jun; 10(2):441-5. PubMed ID: 150078
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological mechanisms in aplastic anemia. III. Arguments against the role of primary immunologic disorders in aplastic anemia: effect of transfusion of blood components on the course of aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulos A
    Przegl Lek; 1982; 39(12):821-3. PubMed ID: 6762620
    [No Abstract]   [Full Text] [Related]  

  • 4. [NK and K cell activity in children with leukemias and aplastic anemias before and after allogeneic bone marrow transplantation].
    Thränhardt H; Prager J; Fuchs D; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):285-92. PubMed ID: 2410337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular cross-match tests before bone-marrow transplantation [proceedings].
    Jeannet M; Legendre C; Speck B
    Pathol Biol (Paris); 1978 Jan; 26(1):17. PubMed ID: 358070
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
    Livnat S; Seigneuret M; Storb R; Prentice RL
    J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection.
    Claas FH; van Rood JJ; Warren RP; Weiden PL; Su PJ; Storb R
    Transplant Proc; 1979 Mar; 11(1):423-6. PubMed ID: 377669
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients.
    Parkman R; Rappeport J; Camitta B; Levey R; Rosen FS
    Transplant Proc; 1978 Mar; 10(1):71-3. PubMed ID: 345568
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful bone marrow transplantation in sensitized recipients.
    Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
    Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 12. Autologous marrow recovery and sensitization to non-HLA antigens after HLA-identical marrow transplantation for aplastic anemia.
    Tsoi MS; Warren RP; Storb R; Witherspoon RP; Mickelson E; Giblett ER; Schanfield MS; Weiden P; Thomas ED
    Exp Hematol; 1983 Jan; 11(1):73-81. PubMed ID: 6219886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation in children. II. Immunologic aspects].
    Muranaka S; Kato S; Arimori S; Nose Y; Yamamura M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1176-86. PubMed ID: 3907243
    [No Abstract]   [Full Text] [Related]  

  • 14. Some possible mechanisms leading to autoimmune destruction of bone marrow cells.
    Thorsby E
    Haematol Blood Transfus; 1979; 24():221-8. PubMed ID: 396176
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune-mediated pathogenesis and management of pediatric aplastic anemia].
    Huang YL; Huang SL
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):153-5. PubMed ID: 16624043
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxicity against HLA-identical sibling lymphocytes: genetic determination and independent segregation of the antigenic system involved.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):67-9. PubMed ID: 345567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic study in bone marrow transplantation. Results of the analysis of 3 cases].
    Májský A; Korínková P; Herzog P; Kout M; Soucek J; Novák JT; Potmĕsilová I; Chudomel V
    Vnitr Lek; 1984 Feb; 30(2):105-15. PubMed ID: 6372233
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of marrow graft rejection by the lymphocyte-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity assays.
    Warren RP; Storb R; Weiden PL; Su PJ; Thomas ED
    Transplantation; 1980 Aug; 30(2):118-21. PubMed ID: 7010706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in children with severe aplastic anemia: reconstitution of cellular immunity.
    Holl RA; Dooren LJ; Vossen JM; Roos MT; Schellekens PT
    Transplantation; 1981 Nov; 32(5):418-23. PubMed ID: 7036458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiopathogenesis of aplastic anemia and of the severe form treated with immunosuppression and bone marrow transplantation].
    Dulley FL; Lotério HA; Massumoto CM; Llacer PE; Chamone Dde A
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(4):167-70. PubMed ID: 2696069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.